Skip to content

The influence of Pain Neuroscience Education associated with Meditation on sleep and functional capacity of adults with Fibromyalgia

Influence of Pain Neuroscience Education associated with Meditation on quality of life, sleep and functional capacity of elderly people with Fibromyalgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-58pgs4
Enrollment
Unknown
Registered
2020-08-19
Start date
2018-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

The study is structured in two groups. The Meditation Group: formed by 10 women aged 40 years or older with fibromyalgia who underwent 13 Mindfulness sessions and the Meditation and Education Group in
formed by 12 women 40 years old or more who underwent 13 Mindfulness sessions, with the difference of participating in 3 individual pain neuroscience classes before starting the meditation interventio
Other
E02.190.525.374

Sponsors

Universidade Federal de São Carlos
Lead Sponsor
Universidade Federal de São Carlos
Collaborator

Eligibility

Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: Being 40 years of age or older, having a medical diagnosis of fibromyalgia, with pain intensity classified as moderate or severe by the Numerical Pain Rating Scale, 0 being considered painless, 1 to 3 mild pain, 4 to 6 moderate pain and 6 to 10 severe pain.

Exclusion criteria

Exclusion criteria: Individuals who showed signs of cognitive decline when scoring below the cut-off point in the Mini Mental State Examination (MMSE) were excluded - in the case of elderly participants; have hip or knee limitations, or difficulties in performing movements at ground level; practice physical activity regularly, corresponding to more than 150 minutes of physical activity weekly; have some acute emotional involvement (an event in the last 5 months that leaves you emotionally vulnerable, such as deaths, accidents and other personal and emotional issues); self-reported obsessive compulsive disorder (OCD); being under fibromyalgia treatment or having undergone it in less than 3 months; having more than 25% of absences in the interventions (equivalent to 3.25 absences).

Design outcomes

Primary

MeasureTime frame
Assess the performance of participants in activities of daily living before and after the intervention using the Katz Scale of Independence in Activities of Daily Living.;Evaluate the performance of participants in instrumental activities of daily living before and after interventions using the Lawton and Brody Instrumental Activities of Daily Living Scale.;Conduct the participants' sleep quality assessment with the Pittsburgh Sleep Quality Index before and after interventions.

Secondary

MeasureTime frame
Conduct an assessment of the mood of the participants using the Geriatric Depression Scale and the Hospital Anxiety and Depression Rating Scale before and after the interventions.;To assess the degree of pain catastrophization in the participants of both groups before and after the proposed interventions using the Pain Catastrophization Scale.;Assess pain intensity using the Numerical Scale for Pain Classification for the pre and post-intervention moments;To verify the level of pain interference in the ability to walk, in activities of daily living, at work, in social activities, in mood and sleep with the use of the Brief Pain Inventory. The pre and post measurements showed differences in some of the questionnaire items.;Evaluate the impact of Fibromyalgia on the participant's health status through the Fibromyalgia Impact Questionnaire in the pre and post-intervention moments for both groups.;Compare the participants' cognitive status before and after the interventions using the Mini-Mental State Examination.;Verify kinesiophobia before and after interventions using the Tampa Scale for Kinesiophobia.

Countries

Brazil

Contacts

Public ContactKarina Say

Universidade Federal de São Carlos

gramanisay@ufscar.br+55-16-3306-6667

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 17, 2026